Moneycontrol PRO
HomeNewsWorldWorld surpasses half a billion known coronavirus cases

World surpasses half a billion known coronavirus cases

More than 5.1 billion people — about 66.4% of the world population — have received at least one dose of a coronavirus vaccine, according to the Our World in Data project at the University of Oxford.

April 13, 2022 / 20:59 IST
(Representative image: Reuters)

The coronavirus is continuing to stalk the world at an astonishing clip, racing past a grim succession of pandemic milestones in 2022: totals of 300 million known cases around the world by early January, 400 million by early February and, as of Tuesday, half a billion.

There have almost certainly been far more infections than that among the global population of 7.9 billion, with many going undetected or unreported, and the reporting gap may only grow wider as some countries, including the United States, scale back official testing.

“That’s dangerous,” Ali Mokdad, an epidemiologist at the University of Washington, and formerly of the Centers for Disease Control and Prevention, said in a recent interview. “If you don’t test, then you don’t know what variants you have.”

Regional officials with the World Health Organization recently urged African countries to ramp up testing and contact tracing, and called for some countries in the Americas to double down on efforts to increase vaccination and testing as cases remained higher in Europe. (Britain, for instance, has ended free testing.) A WHO analysis also recently estimated that 65% of Africans had been infected with the coronavirus as of September 2021, nearly 100 times the number of confirmed cases on the continent.

The number of new cases reported around the globe each day has been declining for some time now; the average over the past week has been about 1.1 million cases a day, according to the Center for Systems Science and Engineering at Johns Hopkins University. That’s about 32% fewer than two weeks ago.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

But over the course of the pandemic, countries with limited public health resources may have detected and confirmed only a tiny fraction of the cases in their populations. And more recent figures may miss many at-home rapid test results that are never officially reported. Many people with infections are never tested at all, because they have no symptoms, or lack access to testing, or want to avoid the consequences of a positive test result, or choose not to for other reasons.

Coronavirus deaths have also been declining. The world reported about 3,800 a day on average over the past week, 23% fewer than two weeks ago.

Still, the director-general of the WHO, Dr. Tedros Adhanom Ghebreyesus, recently said that the world remains in the acute phase of the pandemic, and many health experts agree.

Experts’ warnings have not stopped many nations from dropping their pandemic precautions almost completely in the two months since the global case count surpassed 400 million. In the United States, the Centers for Disease Control and Prevention issued new guidelines in late February suggesting that most Americans could stop wearing masks, and no longer needed to maintain social distance or avoid crowded indoor spaces.

“What’s happening globally and in the U.S.,” Mokdad said, “is that people basically gave up. They just want to go back to normal life.”

That desire is threatened by the swift spread of the omicron subvariant known as BA.2, the most transmissible version of the virus yet identified. BA.2 now accounts for the vast majority of new cases in the United States and around the world; it has spread even faster than BA.1, which helped fuel surges over the winter.

The peak of the most recent surge may have passed in some parts of Europe, but Hong Kong is still trying to escape an outbreak that began in January, and Shanghai residents are under lockdown and reporting food shortages.

“The focus on new cases is warranted,” Crystal Watson, a senior scholar at the Johns Hopkins Center for Health Security, said in a recent interview. “What we’re seeing in China is a very extreme surge in cases, because they have not had a lot of exposure there, and the vaccine is less effective there.”

More than 5.1 billion people — about 66.4% of the world population — have received at least one dose of a coronavirus vaccine, according to the Our World in Data project at the University of Oxford. More than 1.7 billion booster shots or additional doses have been administered globally. But coverage varies starkly among regions. Africa’s rates are the lowest of any continent, with about 20% of people having received at least one dose.

This article originally appeared in The New York Times.

By Adeel Hassan

c.2022 The New York Times Company

New York Times
first published: Apr 13, 2022 08:59 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347